Referencje kliniczne: Wu BB, Gao Rui. et. al. Application of targeted next generation sequencing in the molecular diagnosis of abnormal mass spectrometry analysis findings. Chin J Evid Based Pediatr. 2015 Feb, Vol10, No1.doi:10.3969/j.issn.1673-5501.2015.01.007 [Chinese].Thong MK. Birth defects registries in the genomics era: challenges and opportunities for developing countries. Front Pediatr. 2014 Jun 16;2:60. doi: 10.3389/fped.2014.00060. eCollection 2014.Rieder MJ, Carleton B. Pharmacogenomics and adverse drug reactions in children. Front Genet. 2014 Apr 16;5:78. doi: 10.3389/fgene.2014.00078. eCollection 2014.Brandi ML. Lessons from next-generation sequencing in genetic skeletal disorders. Bonekey Rep. 2014 May 14;3:528. doi: 10.1038/bonekey.2014.23. eCollection 2014.Waisbren SE. et.al. Parents are interested in newborn genomic testing during the Elary postpartum period. Genet Med. 2014 Dec 4. doi: 10.1038/gim.2014.139.Christianson A., Howson C., Modell B, March of Dimes, Global Report On Birth Defects, p2, March of Dimes Birth Defects Foundation White Plains, New York 2006.Watson M. et al, Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary, American College of Medical Genetics Newborn Screening Expert Group, PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275); published in the public domain by the American Academy of Pediatrics.